PeppiLibrary

Cognitive

Oxytocin peptide reference

Endogenous nonapeptide. Bonding, social cognition, labor induction.

Last reviewed May 6, 2026 FDA-approved FDA approved
Peppi reviewing Oxytocin notes
Default dose label24 mcg
Preferred routeIntranasal (for CNS effects); IV/IM for obstetric indications
Frequency labelAs needed; commonly 1–2× daily
Storage window30 days mixed

Evidence snapshot

FDA-approved

Evidence maturityFDA approved
FDA-approved for obstetric indications; research-only for social/cognitive use

Prescription medication

Route map

How records are usually labeled

1 Intranasal
2 SubQ
3 IM
4 IV

Alternate nostrils.

Vial timeline

Storage cues to log

Before mixRefrigerate 2–8 °C.
After mixPer product label; nasal sprays typically 30 days after first use.
Use-by cue30 days after mixing
Mixed vial window30 days
Use this as a record-keeping cue, not a replacement for product labeling.

Peppi workflow

From vial to review

Vial label
Dose 24 mcg
Route Intranasal (for CNS effects); IV/IM for obstetric indications
Review 30d storage

Peppi turns scattered dose, vial, route, storage, note, and report details into one record trail.

Educational reference only

This page helps you understand what to track for Oxytocin. It is not medical advice, a prescription, or a recommendation to use this peptide. Discuss dose, route, timing, storage, and safety with a qualified healthcare professional.

Overview

Oxytocin is a 9-amino-acid cyclic peptide hormone synthesised in the hypothalamus and released by the posterior pituitary. It mediates uterine contractions, milk ejection, and a wide range of social-bonding and stress-modulation behaviors. FDA-approved as IV/IM Pitocin for labor induction and postpartum hemorrhage. Off-label intranasal use for social cognition, anxiety, and bonding research is widespread.

Also known as: Pitocin, Syntocinon.

Labor induction (FDA, IV/IM)Postpartum hemorrhage (FDA)Social anxiety research (off-label intranasal)Autism social-cognition research

Mechanism and timing snapshot

Binds oxytocin receptors (OXTR) in uterus, breast tissue, and CNS. Central effects include modulation of amygdala activity, social-recognition memory, and stress response.

Onset label5 min
Catalog onset field, when available.
Half-life label4 min
Plasma half-life ~3–4 minutes; nasal CNS effects last ~30–60 min
Duration label1 hr
Catalog duration field, when available.
intranasal Limited but reaches CNS
subQ High systemic, limited CNS
IV High systemic, limited CNS

Tracking defaults

These values come from Peppi's catalog so records can be prefilled consistently. They should be reviewed against your clinician's instructions before logging real-world use.

Catalog default dose24 mcg
Catalog dose range16 mcg - 40 mcg
Default routeIntranasal
Frequency labelAs needed; commonly 1–2× daily
Best time labelPre-social activity if seeking social-cognition effects.
Food noteNone.

Catalog protocol note

Research dose: 24 IU (~40 mcg) intranasally as a single dose; effects last ~30–60 min.

Routes and site notes

Available route labelsIntranasal, SubQ, IM, IV
Preferred route labelIntranasal (for CNS effects); IV/IM for obstetric indications
Common site labelsBoth nostrils (intranasal)
Site rotation noteAlternate nostrils.

Chemistry

SequenceCys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (cyclic via Cys-Cys disulfide)
Amino acids9
Molecular formulaC43H66N12O12S2
Molecular weight1007.19 Da

Vial, reconstitution, and storage

Supply formPre-formulated nasal spray or injectable solution
Typical vial sizeNot listed
DiluentPre-formulated; do not reconstitute
Diluent volumeNot listed
Concentration noteCommercial nasal sprays are pre-dosed (typically 4 IU per spray).
Before reconstitutionRefrigerate 2–8 °C.
After reconstitutionPer product label; nasal sprays typically 30 days after first use.
Reconstituted shelf life30 days
Light sensitiveYes
Freeze/thaw warningYes

Safety notes

Common and rare side effects listed in the catalog

  • Generally well-tolerated
  • Mild nasal irritation
  • Slight increase in heart rate
  • Hyponatremia with large IV doses
  • Allergic reaction

Contraindications and warnings

  • Pregnancy unless under obstetric supervision
  • Severe cardiovascular disease
  • Do not self-administer for labor induction.
  • Effects on social cognition vary widely between individuals.

Other considerations

  • Subjective social-bonding effects are real but subtle in research.
  • Intranasal CNS bioavailability is limited — large doses don't proportionally help.
  • Long-term daily use is poorly characterised.

Evidence and regulatory context

Evidence levelFDA-approved for obstetric indications; research-only for social/cognitive use
FDA approvedYes
Regulatory statusPrescription medication
Prescription requiredYes
Approved countriesUS, EU, and most others

Stacking and cycle notes

Stacks well withNot listed
Avoid combining noteNot listed
Typical cycle labelAs needed
Typical break labelN/A
Cycle guidanceEpisodic dosing rather than continuous.

Tracking tips

  • Subjective effects are subtle — manage expectations.
  • Take ~30 min before a social context if using for that purpose.
  • Don't combine with vasoconstrictors or use during pregnancy without medical supervision.

References

Track it in Peppi

Keep Oxytocin records organized.

Use Peppi for dose logs, vial inventory, storage dates, reminders, journal notes, photos, and clinician-ready reports.

Download on theApp Store Get it onGoogle Play

FAQ

What should I track for Oxytocin?

Track the peptide name, dose amount and unit, route, vial label, timing, reconstitution or expiration dates, storage notes, and any symptoms or questions for clinician review.

Does Peppi tell me how to use Oxytocin?

No. Peppi organizes educational reference and your own records. Protocol decisions should come from a qualified healthcare professional.

Can I export Oxytocin records?

Peppi is designed to keep dose logs, vial inventory, journal notes, and reports easier to review and export.

Last reviewed: May 6, 2026